Bio-meds go for funds

Six Israeli bio-techs pitched their therapies to investors at the Azrieli College of Engineering. Concenter (type-2 diabetes treatment), Omnysense (hi-tech thermometer), Omnix (antibiotic), Neurogenesis (neuron injections), Vaxil (anti-cancer vaccine) and Virucure (anti-cancer virus).

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

One Response to Bio-meds go for funds

  1. Pingback: Investment in Israeli startups (8/11/20) - Israel Active

Leave a Reply

Your email address will not be published. Required fields are marked *